News

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...
The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many ...
The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...
Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...